• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

混合性结缔组织病的不同表型:亚组与生存。

Distinct phenotypes in mixed connective tissue disease: subgroups and survival.

机构信息

Institute of Immunology, Oslo University Hospital, Oslo, Norway.

出版信息

Lupus. 2012 Nov;21(13):1412-22. doi: 10.1177/0961203312456751. Epub 2012 Aug 3.

DOI:10.1177/0961203312456751
PMID:22864236
Abstract

The aim of the present study was to assess the autoantibody profile, dominant clinical symptoms and cluster characteristics of different mixed connective tissue disease (MCTD phenotypes. Two-hundred-and-one patients with MCTD were followed-up longitudinally. Five clinical parameters, Raynaud's phenomenon, pulmonary artery hypertension (PAH), myositis, interstitial lung disease (ILD), erosive arthritis and five auto-antibodies besides anti-U1RNP, antiendothelial cell antibodies (AECA), anti-CCP, anti-cardiolipin (anti-CL), anti-SSA/SSB and IgM rheumatoid factor (RF) were selected for cluster analysis. The mean age of patients was 52.9 ± 12.4 years and the mean follow-up of the disease was 12.5 ± 7.2 years. Patients were classified into three cluster groups. Cluster 1 with 77 patients, cluster 2 with 79 patients and cluster 3 with 45 patients. In cluster 1 the prevalence of PAH (55.8%; p < 0.001), Raynaud's phenomenon (92.2%; p < 0.001) and livedo reticularis (24.6%, p < 0.001) was significantly greater than in cluster 2 and 3. In cluster 2, the incidence of ILD (98.7%; p < 0.001), myositis (77.2%; p < 0.001), and esophageal dysmotility (89.8%; p < 0.001) was significantly greater than that in cluster 1 and 3. In cluster 3, anti-CCP antibodies were present in 31 of 45 patients (68.8%) with erosions. Anti-CCP antibodies were present in 37 of 42 patients (88.0%) with erosions. PAH, angina, venous thrombosis was observed in cluster 1 and pulmonary fibrosis in cluster 2, musculosceletal damage, gastrointestinal symptoms and osteoporotic fractures were most frequent in cluster 3. Cumulative survival assessment indicated cluster 1 patients having the worst prognosis. Cluster analysis is valuable to differentiate among various subsets of MCTD and useful prognostic factor regarding the disease course.

摘要

本研究旨在评估不同混合性结缔组织病(MCTD)表型的自身抗体谱、主要临床症状和聚类特征。211 例 MCTD 患者进行了纵向随访。选择 5 个临床参数(雷诺现象、肺动脉高压(PAH)、肌炎、间质性肺病(ILD)、侵蚀性关节炎)和 5 种自身抗体(除抗 U1RNP 外,还包括抗内皮细胞抗体(AECA)、抗环瓜氨酸肽(抗 CCP)、抗心磷脂(抗 CL)、抗 SSA/SSB 和 IgM 类风湿因子(RF))进行聚类分析。患者的平均年龄为 52.9±12.4 岁,疾病的平均随访时间为 12.5±7.2 年。患者分为 3 个聚类组。聚类 1 有 77 例,聚类 2 有 79 例,聚类 3 有 45 例。在聚类 1 中,PAH(55.8%;p<0.001)、雷诺现象(92.2%;p<0.001)和网状青斑(24.6%;p<0.001)的患病率明显高于聚类 2 和 3。在聚类 2 中,ILD(98.7%;p<0.001)、肌炎(77.2%;p<0.001)和食管动力障碍(89.8%;p<0.001)的发生率明显高于聚类 1 和 3。在聚类 3 中,45 例中有 31 例(68.8%)有侵蚀性病变的患者存在抗 CCP 抗体,42 例中有 37 例(88.0%)有侵蚀性病变的患者存在抗 CCP 抗体。PAH、心绞痛、静脉血栓形成见于聚类 1,肺纤维化见于聚类 2,肌肉骨骼损伤、胃肠道症状和骨质疏松性骨折最常见于聚类 3。累积生存评估表明聚类 1 患者的预后最差。聚类分析有助于区分不同的 MCTD 亚型,对疾病过程具有有用的预后因素。

相似文献

1
Distinct phenotypes in mixed connective tissue disease: subgroups and survival.混合性结缔组织病的不同表型:亚组与生存。
Lupus. 2012 Nov;21(13):1412-22. doi: 10.1177/0961203312456751. Epub 2012 Aug 3.
2
Pulmonary hypertension not a major feature of early mixed connective tissue disease: a prospective clinicoserological study.肺动脉高压并非早期混合性结缔组织病的主要特征:一项前瞻性临床血清学研究。
J Postgrad Med. 2005 Apr-Jun;51(2):104-7, discussion 107-8.
3
Clinical course, prognosis, and causes of death in mixed connective tissue disease.混合性结缔组织病的临床病程、预后和死亡原因。
J Rheumatol. 2013 Jul;40(7):1134-42. doi: 10.3899/jrheum.121272. Epub 2013 May 1.
4
Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension.与肺动脉高压相关的混合性结缔组织病的临床和免疫血清学特征
Scand J Immunol. 2006 Jul;64(1):69-76. doi: 10.1111/j.1365-3083.2006.01770.x.
5
Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.抗RNP抗体患者的临床病程。对32例患者的前瞻性研究。
J Rheumatol. 1991 Oct;18(10):1511-9.
6
[Clinical analysis of 79 pulmonary arterial hypertension cases from 1892 connective tissue disease patients].[1892例结缔组织病患者中79例肺动脉高压的临床分析]
Zhonghua Yi Xue Za Zhi. 2009 Nov 10;89(41):2934-7.
7
Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels.混合性结缔组织病患者的感音神经性听力损失:免疫标志物和细胞因子水平
J Rheumatol. 2009 Sep;36(9):1930-6. doi: 10.3899/jrheum.081314. Epub 2009 Aug 14.
8
Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.混合性结缔组织病的长期预后:纵向临床和血清学研究结果
Arthritis Rheum. 1999 May;42(5):899-909. doi: 10.1002/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L.
9
The diagnosis and classification of mixed connective tissue disease.混合性结缔组织病的诊断与分类。
J Autoimmun. 2014 Feb-Mar;48-49:46-9. doi: 10.1016/j.jaut.2014.01.008. Epub 2014 Jan 22.
10
Mixed connective tissue disease--clinical and immunological profile.混合性结缔组织病——临床与免疫学特征
J Assoc Physicians India. 2001 Apr;49:412-4.

引用本文的文献

1
Prevalence, molecular mechanisms and diagnostic approaches to pulmonary arterial hypertension in connective tissue diseases.结缔组织病相关肺动脉高压的患病率、分子机制及诊断方法
Rheumatol Int. 2025 Apr 4;45(4):87. doi: 10.1007/s00296-025-05845-z.
2
Risk Factors for Adverse Outcomes in Connective Tissue Disease-Associated Pulmonary Hypertension.结缔组织病相关肺动脉高压不良结局的危险因素
Rev Cardiovasc Med. 2025 Mar 17;26(3):26877. doi: 10.31083/RCM26877. eCollection 2025 Mar.
3
Screening, diagnosis, and monitoring of interstitial lung disease in autoimmune rheumatic diseases: A narrative review.
自身免疫性风湿性疾病中间质性肺疾病的筛查、诊断及监测:一篇叙述性综述
Rev Colomb Reumatol. 2024 Apr;31(Suppl 1):S3-S14. doi: 10.1016/j.rcreu.2023.06.002. Epub 2023 Aug 26.
4
Naifold capillaroscopy in mixed connective tissue disease patients.混合性结缔组织病患者的甲襞毛细血管镜检查
Clin Rheumatol. 2024 May;43(5):1703-1709. doi: 10.1007/s10067-024-06879-7. Epub 2024 Mar 21.
5
Mixed Connective Tissue Disease: The Two Cases Representing the Range of this Illness.混合性结缔组织病:两个病例代表了这种疾病的范围。
Curr Rheumatol Rev. 2024;20(5):569-573. doi: 10.2174/0115733971263972231124111042.
6
Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.结缔组织病相关性肺动脉高压:流行病学、发病机制与治疗。
Clin Rheumatol. 2023 Oct;42(10):2601-2610. doi: 10.1007/s10067-022-06446-y. Epub 2022 Nov 17.
7
A Man With Malaise, Myalgia, and Rapidly Progressive Interstitial Lung Disease.一名出现不适、肌肉疼痛和快速进展性间质性肺病的男性。
Chest. 2022 Sep;162(3):e111-e116. doi: 10.1016/j.chest.2022.03.052.
8
The diagnostic challenge of patients with anti-U1-RNP antibodies.抗U1-RNP抗体患者的诊断挑战
Rheumatol Int. 2023 Mar;43(3):509-521. doi: 10.1007/s00296-022-05161-w. Epub 2022 Jul 27.
9
Phenotypic clusters and survival analyses in interstitial pneumonia with myositis-specific autoantibodies.伴有肌炎特异性自身抗体的间质性肺炎的表型聚类和生存分析。
Sarcoidosis Vasc Diffuse Lung Dis. 2022;38(4):e2021047. doi: 10.36141/svdld.v38i4.11368. Epub 2022 Jan 13.
10
Interstitial Lung Disease in Connective Tissue Diseases: Survival Patterns in a Population-Based Cohort.结缔组织病相关间质性肺疾病:基于人群队列的生存模式
J Clin Med. 2021 Oct 21;10(21):4830. doi: 10.3390/jcm10214830.